Phase IIa study of T-5224 in RA patients

Trial Profile

Phase IIa study of T-5224 in RA patients

Phase of Trial: Phase II

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs T 5224 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Toyama Chemical
  • Most Recent Events

    • 02 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top